Company Filing History:
Years Active: 1976
Title: By Yan-Voldemar Ozol: A Pioneer in Antiepileptic Compounds
Introduction
By Yan-Voldemar Ozol is an accomplished inventor and administrator based in Riga, Latvia. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antiepileptic compounds. His innovative work has led to the creation of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Ozol holds a patent for a methylamino derivative of 2-ethylindandione-1,3, which includes hydrochloride forms of antiepileptic compounds. The formula is designed to provide effective treatment options for epilepsy, demonstrating his commitment to improving patient outcomes. This patent is a testament to his innovative approach in the pharmaceutical industry, with a focus on creating compounds that can significantly impact the lives of those affected by epilepsy. He has 1 patent to his name.
Career Highlights
Ozol is currently affiliated with the Institut Organicheskogo Sinteza, where he continues to engage in groundbreaking research. His role as an administrator allows him to oversee various projects and collaborate with other experts in the field. His career is marked by a dedication to scientific advancement and a passion for developing new therapeutic solutions.
Collaborations
Throughout his career, Ozol has worked alongside notable colleagues, including Gustav Yanovich Vanags, who is now deceased, and Yan-Voldemar Y Ozol. These collaborations have enriched his research and contributed to the success of his projects.
Conclusion
By Yan-Voldemar Ozol is a distinguished inventor whose work in antiepileptic compounds has made a lasting impact on the field of medicinal chemistry. His innovative spirit and dedication to research continue to inspire future advancements in the treatment of epilepsy.